Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia

Siham Al Sinani, Yusria Al Rawahi, Hamed Abdoon

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

A number of disorders have been described to cause protein losing enteropathy (PLE) in children. Primary intestinal lymphangiectasia (PIL) is one mechanism leading to PLE. Few syndromes are associated with PIL; Hennekam syndrome (HS) is one of them. The principal treatment for PIL is a high protein, low fat diet with medium chain triglycerides supplementation. Supportive therapy includes albumin infusion. Few publications have supported the use of octreotide to diminish protein loss and minimize hypoalbuminemia seen in PIL. There are no publications on the treatment of PIL with octreotide in patients with HS. We report two children with HS and PLE in which we used octreotide to decrease intestinal protein loss. In one patient, octreotide increased serum albumin to an acceptable level without further need for albumin infusions. The other patient responded more dramatically with near normal serum albumin levels and cessation of albumin infusions. In achieving a good response to octreotide in both patients, we add to the publications supporting the use of octreotide in PIL and suggest that octreotide should be tried in patients with PIL secondary to HS. To the best of our knowledge, this is the first case report on the use of octreotide in HSassociated PIL.

Original languageEnglish
Pages (from-to)6333-6337
Number of pages5
JournalWorld Journal of Gastroenterology
Volume18
Issue number43
DOIs
Publication statusPublished - 2012

Fingerprint

Intestinal Lymphangiectasis
Octreotide
Protein-Losing Enteropathies
Publications
Albumins
Serum Albumin
Hypoalbuminemia
Fat-Restricted Diet
Proteins
Triglycerides
Therapeutics

Keywords

  • Hennekam syndrome
  • Lymphangiectasia
  • Octreotide
  • Protein losing enteropathy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia. / Al Sinani, Siham; Al Rawahi, Yusria; Abdoon, Hamed.

In: World Journal of Gastroenterology, Vol. 18, No. 43, 2012, p. 6333-6337.

Research output: Contribution to journalArticle

Al Sinani, Siham ; Al Rawahi, Yusria ; Abdoon, Hamed. / Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia. In: World Journal of Gastroenterology. 2012 ; Vol. 18, No. 43. pp. 6333-6337.
@article{891eeb5cb6d24255842bf5ea6481f190,
title = "Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia",
abstract = "A number of disorders have been described to cause protein losing enteropathy (PLE) in children. Primary intestinal lymphangiectasia (PIL) is one mechanism leading to PLE. Few syndromes are associated with PIL; Hennekam syndrome (HS) is one of them. The principal treatment for PIL is a high protein, low fat diet with medium chain triglycerides supplementation. Supportive therapy includes albumin infusion. Few publications have supported the use of octreotide to diminish protein loss and minimize hypoalbuminemia seen in PIL. There are no publications on the treatment of PIL with octreotide in patients with HS. We report two children with HS and PLE in which we used octreotide to decrease intestinal protein loss. In one patient, octreotide increased serum albumin to an acceptable level without further need for albumin infusions. The other patient responded more dramatically with near normal serum albumin levels and cessation of albumin infusions. In achieving a good response to octreotide in both patients, we add to the publications supporting the use of octreotide in PIL and suggest that octreotide should be tried in patients with PIL secondary to HS. To the best of our knowledge, this is the first case report on the use of octreotide in HSassociated PIL.",
keywords = "Hennekam syndrome, Lymphangiectasia, Octreotide, Protein losing enteropathy",
author = "{Al Sinani}, Siham and {Al Rawahi}, Yusria and Hamed Abdoon",
year = "2012",
doi = "10.3748/wjg.v18.i43.6333",
language = "English",
volume = "18",
pages = "6333--6337",
journal = "World Journal of Gastroenterology",
issn = "1007-9327",
publisher = "WJG Press",
number = "43",

}

TY - JOUR

T1 - Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia

AU - Al Sinani, Siham

AU - Al Rawahi, Yusria

AU - Abdoon, Hamed

PY - 2012

Y1 - 2012

N2 - A number of disorders have been described to cause protein losing enteropathy (PLE) in children. Primary intestinal lymphangiectasia (PIL) is one mechanism leading to PLE. Few syndromes are associated with PIL; Hennekam syndrome (HS) is one of them. The principal treatment for PIL is a high protein, low fat diet with medium chain triglycerides supplementation. Supportive therapy includes albumin infusion. Few publications have supported the use of octreotide to diminish protein loss and minimize hypoalbuminemia seen in PIL. There are no publications on the treatment of PIL with octreotide in patients with HS. We report two children with HS and PLE in which we used octreotide to decrease intestinal protein loss. In one patient, octreotide increased serum albumin to an acceptable level without further need for albumin infusions. The other patient responded more dramatically with near normal serum albumin levels and cessation of albumin infusions. In achieving a good response to octreotide in both patients, we add to the publications supporting the use of octreotide in PIL and suggest that octreotide should be tried in patients with PIL secondary to HS. To the best of our knowledge, this is the first case report on the use of octreotide in HSassociated PIL.

AB - A number of disorders have been described to cause protein losing enteropathy (PLE) in children. Primary intestinal lymphangiectasia (PIL) is one mechanism leading to PLE. Few syndromes are associated with PIL; Hennekam syndrome (HS) is one of them. The principal treatment for PIL is a high protein, low fat diet with medium chain triglycerides supplementation. Supportive therapy includes albumin infusion. Few publications have supported the use of octreotide to diminish protein loss and minimize hypoalbuminemia seen in PIL. There are no publications on the treatment of PIL with octreotide in patients with HS. We report two children with HS and PLE in which we used octreotide to decrease intestinal protein loss. In one patient, octreotide increased serum albumin to an acceptable level without further need for albumin infusions. The other patient responded more dramatically with near normal serum albumin levels and cessation of albumin infusions. In achieving a good response to octreotide in both patients, we add to the publications supporting the use of octreotide in PIL and suggest that octreotide should be tried in patients with PIL secondary to HS. To the best of our knowledge, this is the first case report on the use of octreotide in HSassociated PIL.

KW - Hennekam syndrome

KW - Lymphangiectasia

KW - Octreotide

KW - Protein losing enteropathy

UR - http://www.scopus.com/inward/record.url?scp=84873915757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873915757&partnerID=8YFLogxK

U2 - 10.3748/wjg.v18.i43.6333

DO - 10.3748/wjg.v18.i43.6333

M3 - Article

C2 - 23180957

AN - SCOPUS:84873915757

VL - 18

SP - 6333

EP - 6337

JO - World Journal of Gastroenterology

JF - World Journal of Gastroenterology

SN - 1007-9327

IS - 43

ER -